Trade XOMA Corporation - XOMA CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.25 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026151% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003929% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
XOMA Corp ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Prev. Close* | 14.06 |
Open* | 13.98 |
1-Year Change* | -21.64% |
Day's Range* | 13.69 - 14.19 |
52 wk Range | 13.68-26.00 |
Average Volume (10 days) | 18.13K |
Average Volume (3 months) | 878.97K |
Market Cap | 171.17M |
P/E Ratio | -100.00K |
Shares Outstanding | 11.47M |
Revenue | 4.03M |
EPS | -2.69 |
Dividend (Yield %) | N/A |
Beta | 0.85 |
Next Earnings Date | Nov 1, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Sep 29, 2023 | 14.06 | -0.10 | -0.71% | 14.16 | 14.42 | 13.80 |
Sep 28, 2023 | 14.21 | -0.13 | -0.91% | 14.34 | 14.66 | 14.16 |
Sep 27, 2023 | 14.42 | 0.43 | 3.07% | 13.99 | 14.61 | 13.77 |
Sep 26, 2023 | 14.20 | -0.09 | -0.63% | 14.29 | 14.72 | 13.97 |
Sep 25, 2023 | 14.66 | 0.18 | 1.24% | 14.48 | 14.75 | 14.47 |
Sep 22, 2023 | 15.46 | 0.09 | 0.59% | 15.37 | 15.72 | 15.24 |
Sep 21, 2023 | 15.70 | 0.01 | 0.06% | 15.69 | 16.17 | 15.39 |
Sep 20, 2023 | 15.69 | -0.28 | -1.75% | 15.97 | 16.19 | 15.34 |
Sep 19, 2023 | 15.97 | 0.10 | 0.63% | 15.87 | 16.42 | 15.87 |
Sep 18, 2023 | 16.23 | -0.76 | -4.47% | 16.99 | 17.18 | 16.20 |
Sep 15, 2023 | 17.18 | 1.49 | 9.50% | 15.69 | 17.43 | 15.59 |
Sep 14, 2023 | 15.98 | 0.51 | 3.30% | 15.47 | 16.12 | 15.47 |
Sep 13, 2023 | 15.68 | 0.88 | 5.95% | 14.80 | 15.90 | 14.80 |
Sep 12, 2023 | 15.42 | 0.10 | 0.65% | 15.32 | 15.57 | 14.81 |
Sep 11, 2023 | 15.59 | 0.47 | 3.11% | 15.12 | 15.59 | 14.48 |
Sep 8, 2023 | 15.17 | 0.55 | 3.76% | 14.62 | 15.17 | 14.62 |
Sep 7, 2023 | 14.88 | 0.66 | 4.64% | 14.22 | 15.05 | 14.02 |
Sep 6, 2023 | 14.72 | 0.55 | 3.88% | 14.17 | 14.72 | 13.88 |
Sep 5, 2023 | 14.46 | 0.48 | 3.43% | 13.98 | 14.68 | 13.97 |
Sep 1, 2023 | 14.23 | 0.26 | 1.86% | 13.97 | 14.23 | 13.57 |
XOMA Corporation Events
Time (UTC) | Country | Event |
---|---|---|
Wednesday, November 1, 2023 | ||
Time (UTC) 12:30 | Country US
| Event Q3 2023 XOMA Corp Earnings Release Q3 2023 XOMA Corp Earnings ReleaseForecast -Previous - |
Thursday, March 7, 2024 | ||
Time (UTC) 13:30 | Country US
| Event Q4 2023 XOMA Corp Earnings Release Q4 2023 XOMA Corp Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 6.027 | 38.16 | 29.385 | 18.37 | 5.299 |
Revenue | 6.027 | 38.16 | 29.385 | 18.37 | 5.299 |
Total Operating Expense | 23.441 | 20.931 | 16.969 | 22.255 | 22.156 |
Selling/General/Admin. Expenses, Total | 23.191 | 20.46 | 16.799 | 21.002 | 18.563 |
Research & Development | 0.153 | 0.171 | 0.17 | 1.253 | 1.682 |
Unusual Expense (Income) | 0 | 0.3 | 1.911 | ||
Operating Income | -17.414 | 17.229 | 12.416 | -3.885 | -16.857 |
Interest Income (Expense), Net Non-Operating | 0.255 | -1.345 | -0.832 | -1.63 | -1.465 |
Other, Net | 0.04 | 0.005 | 0.213 | 3.533 | 4.881 |
Net Income Before Taxes | -17.119 | 15.889 | 11.797 | -1.982 | -13.441 |
Net Income After Taxes | -17.104 | 15.798 | 13.298 | -1.982 | -13.343 |
Net Income Before Extra. Items | -17.104 | 15.798 | 13.298 | -1.982 | -13.343 |
Net Income | -17.104 | 15.798 | 13.298 | -1.982 | -13.343 |
Income Available to Common Excl. Extra. Items | -22.576 | 7.968 | 9.01 | -1.982 | -13.343 |
Income Available to Common Incl. Extra. Items | -22.576 | 7.968 | 9.01 | -1.982 | -13.343 |
Diluted Net Income | -22.576 | 7.968 | 9.01 | -1.982 | -13.343 |
Diluted Weighted Average Shares | 11.413 | 12.192 | 11.503 | 8.763 | 8.373 |
Diluted EPS Excluding Extraordinary Items | -1.9781 | 0.65354 | 0.78327 | -0.22618 | -1.59357 |
Diluted Normalized EPS | -1.9781 | 0.67801 | 0.78327 | -0.22618 | -1.44522 |
Total Adjustments to Net Income | -5.472 | -7.83 | -4.288 | 0 | |
Dilution Adjustment | 0 | ||||
Depreciation / Amortization | 0.097 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 1.658 | 0.437 | 1.486 | 0.451 | 0.983 |
Revenue | 1.658 | 0.437 | 1.486 | 0.451 | 0.983 |
Total Operating Expense | 7.615 | 10.607 | 7.696 | 4.823 | 5.75 |
Selling/General/Admin. Expenses, Total | 5.777 | 6.196 | 7.571 | 4.794 | 5.71 |
Research & Development | 0.039 | 0.054 | 0.028 | 0.029 | 0.04 |
Operating Income | -5.957 | -10.17 | -6.21 | -4.372 | -4.767 |
Interest Income (Expense), Net Non-Operating | 0.557 | 0.357 | 0.214 | 0.194 | 0.058 |
Other, Net | 0 | 0 | 0.005 | 0 | 0.039 |
Net Income Before Taxes | -5.4 | -9.813 | -5.991 | -4.178 | -4.67 |
Net Income After Taxes | -5.4 | -9.813 | -5.976 | -4.178 | -4.67 |
Net Income Before Extra. Items | -5.4 | -9.813 | -5.976 | -4.178 | -4.67 |
Net Income | -5.4 | -9.813 | -5.976 | -4.178 | -4.67 |
Total Adjustments to Net Income | -1.368 | -1.368 | -1.368 | -1.368 | -1.368 |
Income Available to Common Excl. Extra. Items | -6.768 | -11.181 | -7.344 | -5.546 | -6.038 |
Income Available to Common Incl. Extra. Items | -6.768 | -11.181 | -7.344 | -5.546 | -6.038 |
Diluted Net Income | -6.768 | -11.181 | -7.344 | -5.546 | -6.038 |
Diluted Weighted Average Shares | 11.466 | 11.46 | 11.452 | 11.447 | 11.421 |
Diluted EPS Excluding Extraordinary Items | -0.59027 | -0.97565 | -0.64129 | -0.48449 | -0.52868 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -0.4529 | -0.97565 | -0.64129 | -0.48449 | -0.52868 |
Unusual Expense (Income) | 1.575 | 0 | 0 | 0 | |
Depreciation / Amortization | 0.224 | 0.225 | 0.097 | ||
Other Operating Expenses, Total | 0 | 4.132 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 61.253 | 96.973 | 88.065 | 59.973 | 47.626 |
Cash and Short Term Investments | 58.161 | 94.102 | 84.222 | 56.688 | 45.78 |
Cash & Equivalents | 56.688 | 45.78 | |||
Short Term Investments | 0.335 | 0.774 | |||
Total Receivables, Net | 2.367 | 0.209 | 1.789 | 2.933 | 1.468 |
Accounts Receivable - Trade, Net | 0.001 | 0.209 | 0.263 | 2.933 | 1.468 |
Prepaid Expenses | 0.725 | 0.613 | 0.443 | 0.352 | 0.378 |
Total Assets | 140.382 | 166.562 | 125.285 | 95.724 | 63.785 |
Property/Plant/Equipment, Total - Net | 0.036 | 0.213 | 0.38 | 0.544 | 0.059 |
Property/Plant/Equipment, Total - Gross | 0.129 | ||||
Accumulated Depreciation, Total | -0.07 | ||||
Other Long Term Assets, Total | 0.26 | 0.301 | 0.572 | 0.151 | 15.708 |
Total Current Liabilities | 6.818 | 12.967 | 12.302 | 8.875 | 5.703 |
Accounts Payable | 0.524 | 1.072 | 0.456 | 0.614 | 1.244 |
Accrued Expenses | 2.952 | 0.72 | 0.821 | 1.108 | 2.298 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 8.088 | 5.184 | 0.789 | |
Other Current Liabilities, Total | 3.342 | 11.175 | 2.937 | 1.969 | 1.372 |
Total Liabilities | 16.368 | 24.686 | 38.861 | 51.736 | 45 |
Total Long Term Debt | 0 | 0 | 12.764 | 27.093 | 21.69 |
Long Term Debt | 0 | 12.764 | 27.093 | 21.69 | |
Other Liabilities, Total | 9.55 | 11.719 | 13.795 | 15.768 | 17.607 |
Total Equity | 124.014 | 141.876 | 86.424 | 43.988 | 18.785 |
Common Stock | 0.086 | 0.085 | 0.084 | 0.073 | 0.065 |
Additional Paid-In Capital | 1306.27 | 1307.03 | 1267.38 | 1238.3 | 1211.12 |
Retained Earnings (Accumulated Deficit) | -1182.39 | -1165.29 | -1181.09 | -1194.38 | -1192.4 |
Total Liabilities & Shareholders’ Equity | 140.382 | 166.562 | 125.285 | 95.724 | 63.785 |
Total Common Shares Outstanding | 11.454 | 11.3153 | 11.2288 | 9.75858 | 8.69072 |
Long Term Investments | 0 | 1.693 | 0.681 | 0.392 | |
Note Receivable - Long Term | 63.683 | 69.075 | 34.575 | 34.375 | |
Cash | 57.826 | 93.328 | 84.222 | ||
Other Current Assets, Total | 0 | 2.049 | 1.611 | ||
Redeemable Preferred Stock | 0.049 | 0.049 | 0.049 | ||
Total Preferred Shares Outstanding | 0.9856 | 0.984 | 0.984 | ||
Intangibles, Net | 15.15 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Total Current Assets | 45.073 | 79.741 | 87.261 | 89.614 | |
Cash and Short Term Investments | 44.611 | 78.728 | 83.705 | 88.343 | |
Cash | 44.3 | 78.285 | 83.182 | 87.796 | |
Total Receivables, Net | 0.006 | 0.016 | 2.505 | 0.025 | |
Accounts Receivable - Trade, Net | 0.006 | 0.016 | 0.005 | 0.025 | |
Prepaid Expenses | 0.456 | 0.997 | 1.051 | 0.409 | |
Other Current Assets, Total | 0 | 0 | 0.837 | ||
Total Assets | 133.664 | 146.131 | 154.222 | 159.16 | |
Property/Plant/Equipment, Total - Net | 0.073 | 0.081 | 0.126 | 0.17 | |
Long Term Investments | |||||
Note Receivable - Long Term | 73.333 | 66.049 | 66.575 | 69.075 | |
Other Long Term Assets, Total | 0.26 | 0.26 | 0.26 | 0.301 | |
Total Current Liabilities | 10.094 | 5.425 | 8.424 | 7.89 | |
Accounts Payable | 0.437 | 0.985 | 1.153 | 0.787 | |
Accrued Expenses | 6.196 | 1.293 | 1.159 | 1.037 | |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | |
Current Port. of LT Debt/Capital Leases | |||||
Other Current Liabilities, Total | 3.461 | 3.147 | 6.112 | 6.066 | |
Total Liabilities | 19.138 | 15.806 | 19.266 | 19.236 | |
Total Long Term Debt | 0 | 0 | 0 | 0 | |
Long Term Debt | |||||
Other Liabilities, Total | 9.044 | 10.381 | 10.842 | 11.346 | |
Total Equity | 114.526 | 130.325 | 134.956 | 139.924 | |
Redeemable Preferred Stock | 0.049 | 0.049 | 0.049 | 0.049 | |
Common Stock | 0.086 | 0.086 | 0.086 | 0.086 | |
Additional Paid-In Capital | 1306.6 | 1306.61 | 1307.06 | 1307.36 | |
Retained Earnings (Accumulated Deficit) | -1192.2 | -1176.42 | -1172.24 | -1167.57 | |
Total Liabilities & Shareholders’ Equity | 133.664 | 146.131 | 154.222 | 159.16 | |
Total Common Shares Outstanding | 11.461 | 11.4508 | 11.4238 | 11.4099 | |
Total Preferred Shares Outstanding | 0.9856 | 0.984 | 0.984 | 0.984 | |
Short Term Investments | 0.311 | 0.443 | 0.523 | 0.547 | |
Intangibles, Net | 14.925 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | -17.104 | 15.798 | 13.298 | -1.982 | -13.343 |
Cash From Operating Activities | -12.879 | 22.678 | 10.092 | -0.285 | -12.644 |
Cash From Operating Activities | 0.007 | 0.007 | 0.022 | 0.025 | 0.03 |
Non-Cash Items | 4.302 | 7.759 | -3.415 | 5.767 | 3.651 |
Cash Interest Paid | 0 | 0.311 | 0.692 | 0.558 | 0.081 |
Changes in Working Capital | -0.181 | -0.886 | 0.187 | -4.095 | -2.982 |
Cash From Investing Activities | -20.221 | -26.5 | -0.209 | -19.3 | -15.006 |
Capital Expenditures | -15.247 | 0 | -0.009 | 0 | -0.006 |
Other Investing Cash Flow Items, Total | -4.974 | -26.5 | -0.2 | -19.3 | -15 |
Cash From Financing Activities | -4.451 | 12.835 | 19.793 | 30.493 | 29.939 |
Issuance (Retirement) of Stock, Net | 2.419 | 41.584 | 29.45 | 22.539 | 22.915 |
Issuance (Retirement) of Debt, Net | 0 | -21.377 | -5.33 | 8.547 | 7.487 |
Foreign Exchange Effects | 0 | 0.02 | |||
Net Change in Cash | -37.551 | 9.013 | 29.676 | 10.908 | 2.309 |
Financing Cash Flow Items | -1.398 | -3.873 | -4.327 | -0.593 | -0.463 |
Cash Taxes Paid | 0.076 | 0 | 1.637 | ||
Total Cash Dividends Paid | -5.472 | -3.499 | |||
Amortization | 0.097 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -9.813 | -17.104 | -11.128 | -6.95 | -2.28 |
Cash From Operating Activities | -4.924 | -12.879 | -8.989 | -5.326 | -1.009 |
Cash From Operating Activities | 0.001 | 0.007 | 0.007 | 0.003 | 0.002 |
Non-Cash Items | 1.764 | 4.302 | 3.162 | 2.235 | 1.332 |
Cash Interest Paid | 0 | 0 | 0 | 0 | 0.095 |
Changes in Working Capital | 2.899 | -0.181 | -1.03 | -0.614 | -0.063 |
Cash From Investing Activities | -7.234 | -20.221 | -4.974 | -5 | -5 |
Other Investing Cash Flow Items, Total | -7.234 | -4.974 | -4.974 | -5 | -5 |
Cash From Financing Activities | -1.368 | -4.451 | -3.129 | -1.869 | -0.735 |
Financing Cash Flow Items | 0 | -1.398 | -1.398 | -1.038 | -0.973 |
Issuance (Retirement) of Stock, Net | 0 | 2.419 | 2.373 | 1.905 | 1.606 |
Issuance (Retirement) of Debt, Net | 0 | 0 | 0 | 0 | |
Net Change in Cash | -13.526 | -37.551 | -17.092 | -12.195 | -6.744 |
Total Cash Dividends Paid | -1.368 | -5.472 | -4.104 | -2.736 | -1.368 |
Capital Expenditures | -15.247 | ||||
Cash Taxes Paid | 0.076 | 0.095 | 0.095 | ||
Amortization | 0.225 | 0.097 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
XOMA Corporation Company profile
About XOMA Corp
XOMA Corporation (XOMA) is a biotechnology royalty aggregator. The Company's drug royalty aggregator business is focused on early to mid-stage clinical assets primarily in Phase I and II. XOMA acquires pre-commercial therapeutic candidates that are licensed to pharmaceutical or biotechnology companies. The Company's portfolio of partner-funded programs spans multiple stages of the drug development process and across various therapeutic areas. The Company's royalty-aggregator business includes acquiring additional licenses to programs with third-party funding and has more than 70 assets. XOMA royalty portfolio includes NIS793, anti-transforming growth factor-beta (TGFb) antibody program; gevokizumab (VPM087); mezagitamab (TAK-079), iscalimab (CFZ533), and MK-4830.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, XOMA Corp revenues increased 30% to $38.2M. Net income applicable to common stockholders decreased 12% to $8M. Revenues reflect Europe segment increase of 40% to $35M, United States segment increase from $1.3M to $2.6M. Net income was offset by Stock-based Compensation in SGA increase of 56% to $6.2M (expense).
Equity composition
Common Stock $.0075 Par, 03/11, 46,666,666 auth., 29,510,963 issd. Insiders own 7.83%. PO: 4/91, 3.4M shs @ $26.50 by Alex. Brown& Sons. PO 6/01, 3M shs @ $15 by U.S. Bancorp Piper Jaffray. Series B Prfd. Stock $.05 Par, 8K auth., 2,959 issd. *1996, Co.'s 4% Conv. Subd. Debentures were conv. into 2M shs. of Common. 08/10, 1-for-15 reverse split.
Industry: | Bio Therapeutic Drugs |
Suite 310
2200 Powell Street
EMERYVILLE
CALIFORNIA 94608
US
Income Statement
- Annual
- Quarterly
News

How to Trade The Triple Top
Welcome to Part 5 of our 7-part Power Patterns series. In this series, we'll be equipping you with the skills to trade some of the most indicative price patterns which occur on any timeframe in every market.
14:13, 27 September 2023
Q4 lookahead: US indices starting to show signs of trouble?
US indices start to draw attention as traders focus on the outlook for Q4.
07:20, 27 September 2023
USD/JPY Climbs Towards Key Highs
USDJPY’s powerful long-term uptrend has been reignited after last week’s sharply contrasting policy statements from the Federal Reserve and Bank of Japan.
11:32, 26 September 2023
EUR/USD tests key support
EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.
14:32, 21 September 2023
BoE leaves rates unchanged, GBP drops further as investors look for more clarity
The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August
11:45, 21 September 2023
GBP softer after CPI surprise, JPY focused on any further hints from Ueda
GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.
12:42, 20 September 2023
How to Trade The Break & Retest
In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.
11:59, 20 September 2023People also watch
Still looking for a broker you can trust?
Join the 555.000+ traders worldwide that chose to trade with Capital.com